The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The SUNEVO (GETNE-1408) trial to evaluate the activity and safety of thecombination of sunitinib with evofosfamide (TH-302) in patients with G1/G2 metastatic pancreatic neuroendocrine tumours (pNETs) naïve forsystemic treatment: A phase II study of the Spanish Task Force Group for Neuroendocrine and Endocrine Tumors (GETNE).
 
Enrique Grande
Honoraria - Advanced Accelerator Applications; Bristol-Myers Squibb; Celgene; Eisai; Eusa Pharma; Genzyme; IPSEN; Lexicon; MSD; Novartis; Pfizer; Pierre Fabre; Roche; Roche
Consulting or Advisory Role - Ipsen; MSD; Pfizer
Research Funding - AstraZeneca (Inst); Ipsen (Inst); MTEM/Threshold (Inst); Pfizer (Inst); Roche
 
Carlos Lopez
Honoraria - Ipsen; Novartis; Pfizer; Roche
Consulting or Advisory Role - Ipsen; Pfizer; Roche
Research Funding - Ipsen; Pfizer; Roche
Travel, Accommodations, Expenses - Ipsen; Pfizer; Roche
 
Teresa Alonso-Gordoa
Research Funding - Roche
Travel, Accommodations, Expenses - Pfizer; Sanofi
 
Marta Benavent
No Relationships to Disclose
 
Jaume Capdevila
Consulting or Advisory Role - Advanced Accelerator Applications; Bayer; Eisai; Exelixis; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi
Speakers' Bureau - Bayer; Eisai; Ipsen; Merck Serono; Novartis; Pfizer; Sanofi
Research Funding - Advanced Accelerator Applications (Inst); AstraZeneca (Inst); Bayer (Inst); Eisai (Inst); Ipsen (Inst); Ipsen (Inst); Novartis (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Eisai; Ipsen; Pfizer
 
Alex Teule
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis; Pfizer
Travel, Accommodations, Expenses - AstraZeneca; Ipsen; Novartis
 
Ana Custodio
No Relationships to Disclose
 
Isabel Sevilla
No Relationships to Disclose
 
Pablo Gajate
Consulting or Advisory Role - Ipsen
Speakers' Bureau - Ipsen
Travel, Accommodations, Expenses - Ipsen
 
Javier Molina-Cerrillo
No Relationships to Disclose
 
Jorge Hernando-Cubero
Speakers' Bureau - Eisai; Roche
Travel, Accommodations, Expenses - Ipsen; Novartis; Roche; Sanofi
 
Rocio Garcia-Carbonero
Honoraria - Advanced Accelerator Applications; AstraZeneca (I); Boehringer Ingelheim (I); Bristol-Myers Squibb; Bristol-Myers Squibb (I); Gilead Sciences (I); Ipsen; Lilly (I); Merck; Merck (I); Novartis; Pfizer; PharmaMar; PharmaMar (I); Roche; Roche (I); Sanofi; SERVIER; SERVIER (I)
Consulting or Advisory Role - Advanced Accelerator Applications; Ipsen; Novartis; Pfizer
Speakers' Bureau - Ipsen; Novartis
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); MSD (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - Merck; Roche